-
Single Molecule Real Time Sequencing - Pacific Biosciences
Revolutionizing new method of superfast DNA sequenzing developed by Pacific Biosciences http://www.pacificbiosciences.com/
-
ME Sports... " Our Background"
ME Sports founders Dr. Jeff Stock and Max Stock talk about the background of Signum Biosciences and ME Sports.
-
DuPont Industrial Biosciences
People may think the science we do at DuPont Industrial Biosciences mostly exists in labs but, in fact, it's everywhere around us. Almost everything we do, e...
-
Introduction to SMRT Sequencing
A brief animated introduction to Pacific Biosciences' single molecule real time (SMRT) sequencing, including the SMRT Cell and ZMW (zero mode waveguide). Not...
-
Sangamo BioSciences
Elizabeth Wolffe, Ph.D., VP, Corporate Communications
(NASDAQ: SGMO)
Headquarters: Richmond, CA
Sangamo BioSciences is focused on Engineering Genetic Cures™ for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic gene regulation and genome editing. The Company has ongoing Phase II clinical trials to evaluate the safety and efficacy of a
-
Assault on AIDS
It's one of the most feared diseases of our time, taking more than 36 million lives. But now a breakthrough in biotech is being talked about as a potential c...
-
Stanford Biosciences
Stanford Biosciences' 13 Home Programs form a collaborative network that encourages creative thinking, interdisciplinary collaboration, and high-stakes, high-reward research. We empower students to broaden their horizons, discover their passion, and become leaders and innovators in their career of choice.
http://biosciences.stanford.edu/
-
ME Sports... "PP2A Part 2: Tau's Connection to Alzheimer's, Diabetes and Cancer"
ME Sports, founders, Dr. Jeff Stock and Max Stock, discuss PP2A.
-
Cardio3 BioSciences Corporate video
Cardio3 BioSciences corporate video
-
A Day in the Life of a Biosciences Student
Current undergraduates Marie and Poppy take you on a tour of a typical day in the life of a Biosciences student at the University of Birmingham.
Presented by Marie Dipple (Biological Sciences, first year) and Poppy Sephton-Clark (Medical Biochemistry, second year) and produced by Robyn Evans (Biological Sciences, second year).
www.birmingham.ac.uk/schools/biosciences
-
"The BD Accuri C6 Flow Cytometer"-David Lee, BD Biosciences
RORTE 2013 presentation - "The BD Accuri C6 Flow Cytometer"-David Lee, BD Biosciences.
-
Valent BioSciences Osage Plant Tour
This is the Grand Opening Tour of our new $150 million biorational manufacturing facility in Osage, Iowa. The first-ever plant designed and dedicated entirel...
-
Aura Biosciences - Non-Invasive Treatment for Ocular Melanoma
In pre-clinical research Aura Biosciences' nanoparticles, called Pseudovirions, have shown great promise for treating Ocular Melanoma while preserving the pa...
-
Présentation de Cardio3 BioSciences à la Société Française des Analystes Financiers
Jeudi 5 février 2015 - Rencontre avec les membres de la direction de Cardio3 BioSciences et discussion sur l’évolution de Cardio3 BioSciences depuis l’IPO de juillet 2013 lors d'une réunion à la Société Française des Analystes.
-
Studying biosciences and university life
Our students and staff talk about the Department of Biology and Biochemistry, explore the University and give a taste of life at Bath.
-
London Zoo | Veterinary Biosciences Placement [University of Surrey]
Video showcasing The University of Surreys veterinary placement program in association with London Zoo. For more information about The University of Surreys ...
-
ME Sports... "Hard Hits: Contact Sports and Your Brain"
ME Sports founders Max Stock and Dr. Jeff Stock, discuss contact sports, hard hits, and the impact on the brain.
-
Staples Spotlight: Confirm Biosciences home testing
From family time to having fun, Zeynep Ilgaz, CEO of Confirm Biosciences, shares her tips on running a small business. For more tips on how to Make More Happen Every Day, check out our Small Business Center: http://bit.ly/1zf35QZ
-
Staples Spotlight: Confirm Biosciences home testing
Zeynep Ilgaz, CEO of Confirm Biosciences, has 3 tips on how she keeps her #SmallBiz business growing. For more tips on how to Make More Happen Every Day, check out our Small Business Center: http://bit.ly/1FVS9bH
-
Proove Biosciences by SmartCEO
-
Harvard i-lab | Venture Incubation Program Summer 2014 Demo Day: Aldatu Biosciences
The Harvard Innovation Lab Venture Incubation Program (VIP) is a 12 week curriculum designed to support Harvard students and help them make progress on their entrepreneurial ventures. We selected 10 startups who have been highly engaged this summer to highlight the diversity of the i-lab and showcase the progress teams are able to make over the 12-week period.
Watch as Aldatu Biosciences present
-
Calithera Biosciences Inc (CALA) Stock Chart Technical Analysis for 12-12-14
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Calithera Biosciences Inc (CALA). For more free videos and content from ClayTrader check out the links below.
J
-
Pre-Veterinary Medicine & Animal Biosciences
At Delaware, Pre-Veterinary Medicine and Animal Biosciences majors have the unique opportunity to work closely with the department's faculty, which includes ...
Single Molecule Real Time Sequencing - Pacific Biosciences
Revolutionizing new method of superfast DNA sequenzing developed by Pacific Biosciences http://www.pacificbiosciences.com/...
Revolutionizing new method of superfast DNA sequenzing developed by Pacific Biosciences http://www.pacificbiosciences.com/
wn.com/Single Molecule Real Time Sequencing Pacific Biosciences
Revolutionizing new method of superfast DNA sequenzing developed by Pacific Biosciences http://www.pacificbiosciences.com/
- published: 21 Oct 2011
- views: 40670
-
author: haemse
ME Sports... " Our Background"
ME Sports founders Dr. Jeff Stock and Max Stock talk about the background of Signum Biosciences and ME Sports....
ME Sports founders Dr. Jeff Stock and Max Stock talk about the background of Signum Biosciences and ME Sports.
wn.com/Me Sports... Our Background
ME Sports founders Dr. Jeff Stock and Max Stock talk about the background of Signum Biosciences and ME Sports.
- published: 11 Sep 2014
- views: 11
DuPont Industrial Biosciences
People may think the science we do at DuPont Industrial Biosciences mostly exists in labs but, in fact, it's everywhere around us. Almost everything we do, e......
People may think the science we do at DuPont Industrial Biosciences mostly exists in labs but, in fact, it's everywhere around us. Almost everything we do, e...
wn.com/Dupont Industrial Biosciences
People may think the science we do at DuPont Industrial Biosciences mostly exists in labs but, in fact, it's everywhere around us. Almost everything we do, e...
- published: 27 Jun 2014
- views: 682
-
author: DuPont
Introduction to SMRT Sequencing
A brief animated introduction to Pacific Biosciences' single molecule real time (SMRT) sequencing, including the SMRT Cell and ZMW (zero mode waveguide). Not......
A brief animated introduction to Pacific Biosciences' single molecule real time (SMRT) sequencing, including the SMRT Cell and ZMW (zero mode waveguide). Not...
wn.com/Introduction To Smrt Sequencing
A brief animated introduction to Pacific Biosciences' single molecule real time (SMRT) sequencing, including the SMRT Cell and ZMW (zero mode waveguide). Not...
Sangamo BioSciences
Elizabeth Wolffe, Ph.D., VP, Corporate Communications
(NASDAQ: SGMO)
Headquarters: Richmond, CA
Sangamo BioSciences is focused on Engineering Genetic Cures™ fo...
Elizabeth Wolffe, Ph.D., VP, Corporate Communications
(NASDAQ: SGMO)
Headquarters: Richmond, CA
Sangamo BioSciences is focused on Engineering Genetic Cures™ for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic gene regulation and genome editing. The Company has ongoing Phase II clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS (SB-728-T) and NGF-AAV for Alzheimer’s disease (CERE-110). Sangamo’s other therapeutic programs are focused on monogenic and rare diseases. The company has formed a strategic collaboration with Shire International GmbH to develop therapeutics for hemophilia, Huntington’s disease and other monogenic diseases, and with Biogen Idec for hemoglobinopathies, such as sickle cell disease and beta-thalassemia. It has also established strategic partnerships with companies in non-therapeutic applications of its technology, including Dow AgroSciences and Sigma-Aldrich Corporation.
www.sangamo.com
wn.com/Sangamo Biosciences
Elizabeth Wolffe, Ph.D., VP, Corporate Communications
(NASDAQ: SGMO)
Headquarters: Richmond, CA
Sangamo BioSciences is focused on Engineering Genetic Cures™ for monogenic and infectious diseases by deploying its novel DNA-binding protein technology platform in therapeutic gene regulation and genome editing. The Company has ongoing Phase II clinical trials to evaluate the safety and efficacy of a novel ZFP Therapeutic® for the treatment of HIV/AIDS (SB-728-T) and NGF-AAV for Alzheimer’s disease (CERE-110). Sangamo’s other therapeutic programs are focused on monogenic and rare diseases. The company has formed a strategic collaboration with Shire International GmbH to develop therapeutics for hemophilia, Huntington’s disease and other monogenic diseases, and with Biogen Idec for hemoglobinopathies, such as sickle cell disease and beta-thalassemia. It has also established strategic partnerships with companies in non-therapeutic applications of its technology, including Dow AgroSciences and Sigma-Aldrich Corporation.
www.sangamo.com
- published: 02 Apr 2015
- views: 5
Assault on AIDS
It's one of the most feared diseases of our time, taking more than 36 million lives. But now a breakthrough in biotech is being talked about as a potential c......
It's one of the most feared diseases of our time, taking more than 36 million lives. But now a breakthrough in biotech is being talked about as a potential c...
wn.com/Assault On Aids
It's one of the most feared diseases of our time, taking more than 36 million lives. But now a breakthrough in biotech is being talked about as a potential c...
- published: 07 Mar 2014
- views: 769
-
author: CNBC
Stanford Biosciences
Stanford Biosciences' 13 Home Programs form a collaborative network that encourages creative thinking, interdisciplinary collaboration, and high-stakes, high-re...
Stanford Biosciences' 13 Home Programs form a collaborative network that encourages creative thinking, interdisciplinary collaboration, and high-stakes, high-reward research. We empower students to broaden their horizons, discover their passion, and become leaders and innovators in their career of choice.
http://biosciences.stanford.edu/
wn.com/Stanford Biosciences
Stanford Biosciences' 13 Home Programs form a collaborative network that encourages creative thinking, interdisciplinary collaboration, and high-stakes, high-reward research. We empower students to broaden their horizons, discover their passion, and become leaders and innovators in their career of choice.
http://biosciences.stanford.edu/
- published: 22 Sep 2013
- views: 15
ME Sports... "PP2A Part 2: Tau's Connection to Alzheimer's, Diabetes and Cancer"
ME Sports, founders, Dr. Jeff Stock and Max Stock, discuss PP2A....
ME Sports, founders, Dr. Jeff Stock and Max Stock, discuss PP2A.
wn.com/Me Sports... Pp2A Part 2 Tau's Connection To Alzheimer's, Diabetes And Cancer
ME Sports, founders, Dr. Jeff Stock and Max Stock, discuss PP2A.
- published: 03 Sep 2014
- views: 17
Cardio3 BioSciences Corporate video
Cardio3 BioSciences corporate video...
Cardio3 BioSciences corporate video
wn.com/Cardio3 Biosciences Corporate Video
Cardio3 BioSciences corporate video
- published: 05 Nov 2014
- views: 59
A Day in the Life of a Biosciences Student
Current undergraduates Marie and Poppy take you on a tour of a typical day in the life of a Biosciences student at the University of Birmingham.
Presented by ...
Current undergraduates Marie and Poppy take you on a tour of a typical day in the life of a Biosciences student at the University of Birmingham.
Presented by Marie Dipple (Biological Sciences, first year) and Poppy Sephton-Clark (Medical Biochemistry, second year) and produced by Robyn Evans (Biological Sciences, second year).
www.birmingham.ac.uk/schools/biosciences
wn.com/A Day In The Life Of A Biosciences Student
Current undergraduates Marie and Poppy take you on a tour of a typical day in the life of a Biosciences student at the University of Birmingham.
Presented by Marie Dipple (Biological Sciences, first year) and Poppy Sephton-Clark (Medical Biochemistry, second year) and produced by Robyn Evans (Biological Sciences, second year).
www.birmingham.ac.uk/schools/biosciences
- published: 17 Dec 2013
- views: 79
"The BD Accuri C6 Flow Cytometer"-David Lee, BD Biosciences
RORTE 2013 presentation - "The BD Accuri C6 Flow Cytometer"-David Lee, BD Biosciences....
RORTE 2013 presentation - "The BD Accuri C6 Flow Cytometer"-David Lee, BD Biosciences.
wn.com/The Bd Accuri C6 Flow Cytometer David Lee, Bd Biosciences
RORTE 2013 presentation - "The BD Accuri C6 Flow Cytometer"-David Lee, BD Biosciences.
- published: 14 Mar 2013
- views: 2430
-
author: Rutgers
Valent BioSciences Osage Plant Tour
This is the Grand Opening Tour of our new $150 million biorational manufacturing facility in Osage, Iowa. The first-ever plant designed and dedicated entirel......
This is the Grand Opening Tour of our new $150 million biorational manufacturing facility in Osage, Iowa. The first-ever plant designed and dedicated entirel...
wn.com/Valent Biosciences Osage Plant Tour
This is the Grand Opening Tour of our new $150 million biorational manufacturing facility in Osage, Iowa. The first-ever plant designed and dedicated entirel...
Aura Biosciences - Non-Invasive Treatment for Ocular Melanoma
In pre-clinical research Aura Biosciences' nanoparticles, called Pseudovirions, have shown great promise for treating Ocular Melanoma while preserving the pa......
In pre-clinical research Aura Biosciences' nanoparticles, called Pseudovirions, have shown great promise for treating Ocular Melanoma while preserving the pa...
wn.com/Aura Biosciences Non Invasive Treatment For Ocular Melanoma
In pre-clinical research Aura Biosciences' nanoparticles, called Pseudovirions, have shown great promise for treating Ocular Melanoma while preserving the pa...
Présentation de Cardio3 BioSciences à la Société Française des Analystes Financiers
Jeudi 5 février 2015 - Rencontre avec les membres de la direction de Cardio3 BioSciences et discussion sur l’évolution de Cardio3 BioSciences depuis l’IPO de ju...
Jeudi 5 février 2015 - Rencontre avec les membres de la direction de Cardio3 BioSciences et discussion sur l’évolution de Cardio3 BioSciences depuis l’IPO de juillet 2013 lors d'une réunion à la Société Française des Analystes.
wn.com/Présentation De Cardio3 Biosciences À La Société Française Des Analystes Financiers
Jeudi 5 février 2015 - Rencontre avec les membres de la direction de Cardio3 BioSciences et discussion sur l’évolution de Cardio3 BioSciences depuis l’IPO de juillet 2013 lors d'une réunion à la Société Française des Analystes.
- published: 10 Feb 2015
- views: 194
Studying biosciences and university life
Our students and staff talk about the Department of Biology and Biochemistry, explore the University and give a taste of life at Bath....
Our students and staff talk about the Department of Biology and Biochemistry, explore the University and give a taste of life at Bath.
wn.com/Studying Biosciences And University Life
Our students and staff talk about the Department of Biology and Biochemistry, explore the University and give a taste of life at Bath.
- published: 06 Mar 2013
- views: 223
-
author: UniofBath
London Zoo | Veterinary Biosciences Placement [University of Surrey]
Video showcasing The University of Surreys veterinary placement program in association with London Zoo. For more information about The University of Surreys ......
Video showcasing The University of Surreys veterinary placement program in association with London Zoo. For more information about The University of Surreys ...
wn.com/London Zoo | Veterinary Biosciences Placement University Of Surrey
Video showcasing The University of Surreys veterinary placement program in association with London Zoo. For more information about The University of Surreys ...
ME Sports... "Hard Hits: Contact Sports and Your Brain"
ME Sports founders Max Stock and Dr. Jeff Stock, discuss contact sports, hard hits, and the impact on the brain....
ME Sports founders Max Stock and Dr. Jeff Stock, discuss contact sports, hard hits, and the impact on the brain.
wn.com/Me Sports... Hard Hits Contact Sports And Your Brain
ME Sports founders Max Stock and Dr. Jeff Stock, discuss contact sports, hard hits, and the impact on the brain.
- published: 03 Sep 2014
- views: 6
-
author: ME Sports
Staples Spotlight: Confirm Biosciences home testing
From family time to having fun, Zeynep Ilgaz, CEO of Confirm Biosciences, shares her tips on running a small business. For more tips on how to Make More Happen ...
From family time to having fun, Zeynep Ilgaz, CEO of Confirm Biosciences, shares her tips on running a small business. For more tips on how to Make More Happen Every Day, check out our Small Business Center: http://bit.ly/1zf35QZ
wn.com/Staples Spotlight Confirm Biosciences Home Testing
From family time to having fun, Zeynep Ilgaz, CEO of Confirm Biosciences, shares her tips on running a small business. For more tips on how to Make More Happen Every Day, check out our Small Business Center: http://bit.ly/1zf35QZ
- published: 17 Oct 2014
- views: 38
Staples Spotlight: Confirm Biosciences home testing
Zeynep Ilgaz, CEO of Confirm Biosciences, has 3 tips on how she keeps her #SmallBiz business growing. For more tips on how to Make More Happen Every Day, check ...
Zeynep Ilgaz, CEO of Confirm Biosciences, has 3 tips on how she keeps her #SmallBiz business growing. For more tips on how to Make More Happen Every Day, check out our Small Business Center: http://bit.ly/1FVS9bH
wn.com/Staples Spotlight Confirm Biosciences Home Testing
Zeynep Ilgaz, CEO of Confirm Biosciences, has 3 tips on how she keeps her #SmallBiz business growing. For more tips on how to Make More Happen Every Day, check out our Small Business Center: http://bit.ly/1FVS9bH
- published: 31 Oct 2014
- views: 17978
Harvard i-lab | Venture Incubation Program Summer 2014 Demo Day: Aldatu Biosciences
The Harvard Innovation Lab Venture Incubation Program (VIP) is a 12 week curriculum designed to support Harvard students and help them make progress on their en...
The Harvard Innovation Lab Venture Incubation Program (VIP) is a 12 week curriculum designed to support Harvard students and help them make progress on their entrepreneurial ventures. We selected 10 startups who have been highly engaged this summer to highlight the diversity of the i-lab and showcase the progress teams are able to make over the 12-week period.
Watch as Aldatu Biosciences presents their venture.
Aldatu Biosciences is improving HIV patient care worldwide with better, faster, and cheaper diagnostic tools. Their affordable drug resistance genotyping test allows clinicians to match patients with effective drugs, improving clinical outcomes and lowering the per patient cost of care.
Learn more about the Harvard Innovation Lab at http://i-lab.harvard.edu/ and follow us on Twitter at http://twitter.com/innovationlab and like us on Facebook at https://www.facebook.com/harvardinnovationlab
wn.com/Harvard I Lab | Venture Incubation Program Summer 2014 Demo Day Aldatu Biosciences
The Harvard Innovation Lab Venture Incubation Program (VIP) is a 12 week curriculum designed to support Harvard students and help them make progress on their entrepreneurial ventures. We selected 10 startups who have been highly engaged this summer to highlight the diversity of the i-lab and showcase the progress teams are able to make over the 12-week period.
Watch as Aldatu Biosciences presents their venture.
Aldatu Biosciences is improving HIV patient care worldwide with better, faster, and cheaper diagnostic tools. Their affordable drug resistance genotyping test allows clinicians to match patients with effective drugs, improving clinical outcomes and lowering the per patient cost of care.
Learn more about the Harvard Innovation Lab at http://i-lab.harvard.edu/ and follow us on Twitter at http://twitter.com/innovationlab and like us on Facebook at https://www.facebook.com/harvardinnovationlab
- published: 10 Sep 2014
- views: 3
Calithera Biosciences Inc (CALA) Stock Chart Technical Analysis for 12-12-14
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=res...
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Calithera Biosciences Inc (CALA). For more free videos and content from ClayTrader check out the links below.
Join My Private Trading Team - http://claytrader.com/innercircle/
Learn to Use Charts - http://claytrader.com/training/
ClayTrader.com is a wholly-owned subsidiary of Guidance Marketing, LLC. Guidance Marketing, LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
wn.com/Calithera Biosciences Inc (Cala) Stock Chart Technical Analysis For 12 12 14
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Calithera Biosciences Inc (CALA). For more free videos and content from ClayTrader check out the links below.
Join My Private Trading Team - http://claytrader.com/innercircle/
Learn to Use Charts - http://claytrader.com/training/
ClayTrader.com is a wholly-owned subsidiary of Guidance Marketing, LLC. Guidance Marketing, LLC and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
- published: 12 Dec 2014
- views: 150
Pre-Veterinary Medicine & Animal Biosciences
At Delaware, Pre-Veterinary Medicine and Animal Biosciences majors have the unique opportunity to work closely with the department's faculty, which includes ......
At Delaware, Pre-Veterinary Medicine and Animal Biosciences majors have the unique opportunity to work closely with the department's faculty, which includes ...
wn.com/Pre Veterinary Medicine Animal Biosciences
At Delaware, Pre-Veterinary Medicine and Animal Biosciences majors have the unique opportunity to work closely with the department's faculty, which includes ...
-
Institut de Recherche en biosciences (UMONS)
Lab'InSight Fermentation dans l'industrie alimentaire
organisé le 29/10/15
à Liège
-
Opal Biosciences Ltd. Sydney Wholesale Investor Sept 2015
-
Carna Biosciences
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information pros
-
Sachs BEF 2015 - Avanish Vellanki, Aptose Biosciences
Investor Presentation at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment. Presentation by Avanish Vellanki, SVP, Chief Businss Officer, Aptose Biosciences
-
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-01-15
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-01-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Pacific Biosciences of
-
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-07-15
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-07-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Pacific Biosciences of
-
Martek Biosciences Corporation
Martek Biosciences Corporation wiki data bio information
-
IntelliCell BioSciences (OTCQB:SVFC) Featured Company
IntelliCell, focused on the expanding regenerative medical markets, has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes.
-
Samba Biosciences Final Presentation BRAID Lean Launchpad Summer '15
Lean LaunchPad for Healthcare and Life Sciences (LLP) teaches scientists and clinicians how to assess whether the idea or technology they have can serve as the basis of a business. The focus of this course is on the marketplace where you must validate your idea to move into the commercial world. This course is being lead by UC BRAID (Biomedical Research Acceleration, Integration & Development) and
-
Saskatchewan BioSciences - Ag-West Bio
A vibrant research cluster has been created in Saskatoon at the University of Saskatchewan and Innovation Place. Learn more about bioscience research and commercialization by contacting Ag-West Bio, Saskatchewan's bioscience industry association: www.agwest.sk.ca
-
SNNLive with Pressure BioSciences, Inc. (OTCQB: PBIO) - Q3 2015 Review
SNNLive caught up with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) at the SeeThruEquity Fall MicroCap Investor Conference 2015 in New York City, NY.
For more information: http://pressurebiosciences.com/
-
Hester Biosciences
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information pros
-
Prof. Arvind M. Lali, Professor Head, Center of Energy Biosciences, Institute of Chemical Technology
SESSION - VIII (Bio-Energy - Biomass - Biofuels)
6th World Renewable Energy Technology Congress-2015
21-23 August 2015 at
Convention Centre-NDCC, Parliament Street, New Delhi, INDIA
-
Sangamo Biosciences - SGMO Stock Chart Technical Analysis for 09-11-15
Sangamo Biosciences - SGMO Stock Chart Technical Analysis for 09-11-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Sangamo Biosciences (SGMO). Watch more
-
International Journal on Bioinformatics & Biosciences
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)
-
Terry Fodey | Agri-Food and Biosciences Institute | UK | Food Technology 2015 | OMICS International
OMICS International: http://conferenceseries.com/
OMICS open access Journals: http://omicsonline.org
Global Medical Conferences: http://conferenceseries.com
Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com
Global Cancer Conferences: http://cancersummit.org
Global Diabetes Conferences: http://diabetesexpo.com
Global Dental Conferences: http://dentalcongress.com
Global Nur
-
Innova Biosciences and Mologic Sign Supply and Licensing Agreement - press release
In this short video Andy Lane, Executive Director at Innova Biosciences, talks about a new supply and licensing agreement between Innova and Mologic covering the use of Innova’s Lightning-Link and InnovaCoat GOLD technologies in Mologic’s kits and services.
For more information and for the full press release, visit our website: https://www.innovabiosciences.com/latest-updates/news/innova-mologic-
-
The Innova Biosciences Antibody Conjugate Generator - Press Release
In this video Dr Andy Lane, Executive Director at Innova Biosciences, talks about our new online generator which allows you to select from a wide range of antibodies and conjugate to one of over 24 labels including enzymes, biotin, fluorescent dyes and gold nanoparticles.
For more information on our Antibody Conjugate Generator please visit our website: www.innovabiosciences.com/products/Antibo
-
SNNLive - Akers Biosciences, Inc. (NASDAQ: AKER)
SNNLive spoke with Raymond F. Akers, Jr., Ph.D., Executive Chairman of the Board for Akers Biosciences, Inc. (NASDAQ: AKER) at the LD Micro Invitational 2015 in Bel Air, CA.
For more information: http://www.akersbiosciences.com/
-
The Celling Biosciences Difference
Celling Life.
-
Vijaya Rao Pidugu | GVK Biosciences | India | Metabolomics 2014 | OMICS International
Title: Bilirubin as a biological marker for metabolic, cardiovascular and oncological disorders; Analysis using GOBIOM database.
3rd International Conference and Exhibition on Metabolomics & Systems Biology
March 24-26, 2014, San Antonio, USA
OMICS International: http://omicsonline.org
Vaccine Conferences: http://conferenceseries.com/immunology-conferences.php
Global Medical Conferences: http
-
Biosciences and chemistry – student and tutor in conversation
Dr David Smith, senior lecturer in biochemistry, talks to Vietnamese student Dinh about his experience of Sheffield Hallam.
Do you want to study in the UK? Find out more about joining our vibrant and friendly student community – http://www.shu.ac.uk/international
-
International Conference on Biosciences 2015 (Courtesy of GreenTV IPB)
original link: http://greentv.ipb.ac.id/videos/international-confrenece-on-bioscience-2015/
conference information: http://www.icobio.event.ipb.ac.id
Institut de Recherche en biosciences (UMONS)
Lab'InSight Fermentation dans l'industrie alimentaire
organisé le 29/10/15
à Liège...
Lab'InSight Fermentation dans l'industrie alimentaire
organisé le 29/10/15
à Liège
wn.com/Institut De Recherche En Biosciences (Umons)
Lab'InSight Fermentation dans l'industrie alimentaire
organisé le 29/10/15
à Liège
- published: 16 Oct 2015
- views: 36
Carna Biosciences
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securit...
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
wn.com/Carna Biosciences
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA. Historical companies’ data, ratios, exchange rate, prices and estimates are provided by Factset research www.factset.com .
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video. The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 14 Oct 2015
- views: 2
Sachs BEF 2015 - Avanish Vellanki, Aptose Biosciences
Investor Presentation at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment. Presentation by Avanish Vellanki, SVP, Chief Businss Offi...
Investor Presentation at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment. Presentation by Avanish Vellanki, SVP, Chief Businss Officer, Aptose Biosciences
wn.com/Sachs Bef 2015 Avanish Vellanki, Aptose Biosciences
Investor Presentation at the 15th Annual Biotech in Europe Forum for Global Partnering and Investment. Presentation by Avanish Vellanki, SVP, Chief Businss Officer, Aptose Biosciences
- published: 08 Oct 2015
- views: 20
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-01-15
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-01-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrade...
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-01-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Pacific Biosciences of California (PACB). Watch more PACB Technical Analysis Videos: https://claytrader.com/stock_chart/PACB/
The Stock Trading Reality Podcast - https://claytrader.com/podcast/
ClayTrader.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
PACB Stock Technical Analysis Stock Chart, PACB Stock Technical Analysis Stock Pick, PACB Stock Technical Analysis Penny Stock, PACB Stock Technical Analysis Penny Stock Pick, PACB Stock Technical Analysis Stock Alert, PACB Stock Technical Analysis How To Read Stock Charts, PACB Stock Technical Analysis Stock Chart Video, PACB Stock Technical Analysis Daily Chart, PACB Stock Technical Analysis Chart Review, PACB Stock Technical Analysis Stock Review
wn.com/Pacific Biosciences Of California Pacb Stock Chart Technical Analysis For 10 01 15
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-01-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Pacific Biosciences of California (PACB). Watch more PACB Technical Analysis Videos: https://claytrader.com/stock_chart/PACB/
The Stock Trading Reality Podcast - https://claytrader.com/podcast/
ClayTrader.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
PACB Stock Technical Analysis Stock Chart, PACB Stock Technical Analysis Stock Pick, PACB Stock Technical Analysis Penny Stock, PACB Stock Technical Analysis Penny Stock Pick, PACB Stock Technical Analysis Stock Alert, PACB Stock Technical Analysis How To Read Stock Charts, PACB Stock Technical Analysis Stock Chart Video, PACB Stock Technical Analysis Daily Chart, PACB Stock Technical Analysis Chart Review, PACB Stock Technical Analysis Stock Review
- published: 01 Oct 2015
- views: 57
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-07-15
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-07-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrade...
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-07-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Pacific Biosciences of California (PACB). Watch more PACB Technical Analysis Videos: https://claytrader.com/stock_chart/PACB/
The Stock Trading Reality Podcast - https://claytrader.com/podcast/
ClayTrader.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
PACB Stock Technical Analysis Stock Chart, PACB Stock Technical Analysis Stock Pick, PACB Stock Technical Analysis Penny Stock, PACB Stock Technical Analysis Penny Stock Pick, PACB Stock Technical Analysis Stock Alert, PACB Stock Technical Analysis How To Read Stock Charts, PACB Stock Technical Analysis Stock Chart Video, PACB Stock Technical Analysis Daily Chart, PACB Stock Technical Analysis Chart Review, PACB Stock Technical Analysis Stock Review
wn.com/Pacific Biosciences Of California Pacb Stock Chart Technical Analysis For 10 07 15
Pacific Biosciences of California - PACB Stock Chart Technical Analysis for 10-07-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: https://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Pacific Biosciences of California (PACB). Watch more PACB Technical Analysis Videos: https://claytrader.com/stock_chart/PACB/
The Stock Trading Reality Podcast - https://claytrader.com/podcast/
ClayTrader.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
PACB Stock Technical Analysis Stock Chart, PACB Stock Technical Analysis Stock Pick, PACB Stock Technical Analysis Penny Stock, PACB Stock Technical Analysis Penny Stock Pick, PACB Stock Technical Analysis Stock Alert, PACB Stock Technical Analysis How To Read Stock Charts, PACB Stock Technical Analysis Stock Chart Video, PACB Stock Technical Analysis Daily Chart, PACB Stock Technical Analysis Chart Review, PACB Stock Technical Analysis Stock Review
- published: 07 Oct 2015
- views: 123
Martek Biosciences Corporation
Martek Biosciences Corporation wiki data bio information...
Martek Biosciences Corporation wiki data bio information
wn.com/Martek Biosciences Corporation
Martek Biosciences Corporation wiki data bio information
- published: 05 Oct 2015
- views: 1
IntelliCell BioSciences (OTCQB:SVFC) Featured Company
IntelliCell, focused on the expanding regenerative medical markets, has developed its own patented technology and protocol to separate adult autologous vascular...
IntelliCell, focused on the expanding regenerative medical markets, has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes.
wn.com/Intellicell Biosciences (Otcqb Svfc) Featured Company
IntelliCell, focused on the expanding regenerative medical markets, has developed its own patented technology and protocol to separate adult autologous vascular cells from adipose tissue without the use of enzymes.
- published: 01 Oct 2015
- views: 5
Samba Biosciences Final Presentation BRAID Lean Launchpad Summer '15
Lean LaunchPad for Healthcare and Life Sciences (LLP) teaches scientists and clinicians how to assess whether the idea or technology they have can serve as the ...
Lean LaunchPad for Healthcare and Life Sciences (LLP) teaches scientists and clinicians how to assess whether the idea or technology they have can serve as the basis of a business. The focus of this course is on the marketplace where you must validate your idea to move into the commercial world. This course is being lead by UC BRAID (Biomedical Research Acceleration, Integration & Development) and welcomes teams that include at least one member with a current affiliation from a University of California campus.
See more at: https://ita.ucsf.edu/education/course...
wn.com/Samba Biosciences Final Presentation Braid Lean Launchpad Summer '15
Lean LaunchPad for Healthcare and Life Sciences (LLP) teaches scientists and clinicians how to assess whether the idea or technology they have can serve as the basis of a business. The focus of this course is on the marketplace where you must validate your idea to move into the commercial world. This course is being lead by UC BRAID (Biomedical Research Acceleration, Integration & Development) and welcomes teams that include at least one member with a current affiliation from a University of California campus.
See more at: https://ita.ucsf.edu/education/course...
- published: 30 Sep 2015
- views: 2
Saskatchewan BioSciences - Ag-West Bio
A vibrant research cluster has been created in Saskatoon at the University of Saskatchewan and Innovation Place. Learn more about bioscience research and commer...
A vibrant research cluster has been created in Saskatoon at the University of Saskatchewan and Innovation Place. Learn more about bioscience research and commercialization by contacting Ag-West Bio, Saskatchewan's bioscience industry association: www.agwest.sk.ca
wn.com/Saskatchewan Biosciences Ag West Bio
A vibrant research cluster has been created in Saskatoon at the University of Saskatchewan and Innovation Place. Learn more about bioscience research and commercialization by contacting Ag-West Bio, Saskatchewan's bioscience industry association: www.agwest.sk.ca
- published: 23 Sep 2015
- views: 1
SNNLive with Pressure BioSciences, Inc. (OTCQB: PBIO) - Q3 2015 Review
SNNLive caught up with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) at the SeeThruEquity Fall MicroCap Investor Conferen...
SNNLive caught up with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) at the SeeThruEquity Fall MicroCap Investor Conference 2015 in New York City, NY.
For more information: http://pressurebiosciences.com/
wn.com/Snnlive With Pressure Biosciences, Inc. (Otcqb Pbio) Q3 2015 Review
SNNLive caught up with Richard T. Schumacher, President and CEO of Pressure BioSciences, Inc. (OTCQB: PBIO) at the SeeThruEquity Fall MicroCap Investor Conference 2015 in New York City, NY.
For more information: http://pressurebiosciences.com/
- published: 17 Sep 2015
- views: 95
Hester Biosciences
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securit...
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA Companies Data is publicly available. Data and calculations have been sourced from our Team, “Sharadar”, (http://www.sharadar.com), Rufus Pollock and from the Open Knowledge Foundation. All data is licensed under the Open Data Commons Public Domain Dedication and License.
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video.
The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
wn.com/Hester Biosciences
VIDEO FINANCIAL REPORTING
Why invest in is the first financial video platform where you can easily search through thousands of videos describing global securities.
About The Video:
We believe that complex financial data could become more approachable using friendly motion-graphic representation combined with an accurate selection of financial data. To guarantee the most effective information prospective we drew inspiration from Benjamin Graham’s book: “The Intelligent Investor”, a pillar of financial philosophy.
For this project any kind of suggestion or critic will be helpful in order to develop and provide the best service as we can. Please visit our site www.whyinvestin.com and leave a massage to us.
Thank you and hope you'll enjoy.
IMPORTANT INFORMATION - DISCLAIMER
THIS VIDEO IS FOR INFORMATION PURPOSES ONLY AND SHOULD NOT BE RELIED UPON AS INVESTMENT ADVICE. This video has been prepared by Whyinvestin (together with its affiliates, “Whyinvestin”) and is not intended to be taken by, and should not be taken by, any individual recipient as investment advice, a recommendation to buy, hold or sell any security, or an offer to sell or a solicitation of offers to purchase any security.
PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. The performance of the companies discussed on this video is not necessarily indicative of the future performances.
Investors should consider the content of this video in conjunction with investment reports, financial statements and other disclosures regarding the valuations and performance of the specific companies discussed herein.
DO NOT RELY ON ANY OPINIONS, PREDICTIONS OR FORWARD-LOOKING STATEMENTS CONTAINED HEREIN. Certain of the information contained in this video constitutes “forward-looking statements” that are inherently unreliable and actual events or results may differ materially from those reflected or contemplated herein. None of Whyinvestin or any of its representatives makes any assurance as to the accuracy of those predictions or forward-looking statements. Whyinvestin expressly disclaims any obligation or undertaking to update or revise any such forward-looking statements.
EXTERNAL SOURCES. Certain information contained herein has been obtained from third-party sources. Although Whyinvestin believes such sources to be reliable, we make no representation as to its accuracy or completeness.
FINANCIAL DATA Companies Data is publicly available. Data and calculations have been sourced from our Team, “Sharadar”, (http://www.sharadar.com), Rufus Pollock and from the Open Knowledge Foundation. All data is licensed under the Open Data Commons Public Domain Dedication and License.
Whyinvestin does not verify any data and disclaims any obligation to do so. Whyinvestin, its data or content providers, the financial exchanges and each of their affiliates and business partners (A) expressly disclaim the accuracy, adequacy, or completeness of any data and (B) shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon. Neither Whyinvestin nor any of our information providers will be liable for any damages relating to your use of the information provided herein.
Please consult your broker or financial representative to verify pricing before executing any trade. Whyinvestin cannot guarantee the accuracy of the exchange rates used in the videos. You should confirm current rates before making any transactions that could be affected by changes in the exchange rates.
You agree not to copy, modify, reformat, download, store, reproduce, reprocess, transmit or redistribute any data or information found herein or use any such data or information in a commercial enterprise without obtaining prior written consent. Please consult your broker or financial representative to verify pricing before executing any trade.
COPYRIGHT “FAIR USE” Whyinvestin doesn’t own any logo different from the whyinvestin’ s logo contained in the video.
The owner of the logos is the subject of the video itself (the company); and all the logos are not authorized by, sponsored by, or associated with the trademark owner .
Whyinvestin uses exclusive rights held by the copyright owner for Educational purposes and for commentary and criticism as part of a news report or published article.
If you are a company, subject of the video and for any reason want to get in contact with Whyinvestin please email:
company@whyinvestin.com
- published: 16 Sep 2015
- views: 1
Prof. Arvind M. Lali, Professor Head, Center of Energy Biosciences, Institute of Chemical Technology
SESSION - VIII (Bio-Energy - Biomass - Biofuels)
6th World Renewable Energy Technology Congress-2015
21-23 August 2015 at
Convention Centre-NDCC, Parliament S...
SESSION - VIII (Bio-Energy - Biomass - Biofuels)
6th World Renewable Energy Technology Congress-2015
21-23 August 2015 at
Convention Centre-NDCC, Parliament Street, New Delhi, INDIA
wn.com/Prof. Arvind M. Lali, Professor Head, Center Of Energy Biosciences, Institute Of Chemical Technology
SESSION - VIII (Bio-Energy - Biomass - Biofuels)
6th World Renewable Energy Technology Congress-2015
21-23 August 2015 at
Convention Centre-NDCC, Parliament Street, New Delhi, INDIA
- published: 15 Sep 2015
- views: 0
Sangamo Biosciences - SGMO Stock Chart Technical Analysis for 09-11-15
Sangamo Biosciences - SGMO Stock Chart Technical Analysis for 09-11-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-G...
Sangamo Biosciences - SGMO Stock Chart Technical Analysis for 09-11-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Sangamo Biosciences (SGMO). Watch more SGMO Technical Analysis Videos: http://claytrader.com/stock_chart/SGMO/
The Stock Trading Reality Podcast - http://claytrader.com/podcast/
ClayTrader.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
SGMO Stock Technical Analysis Stock Chart, SGMO Stock Technical Analysis Stock Pick, SGMO Stock Technical Analysis Penny Stock, SGMO Stock Technical Analysis Penny Stock Pick, SGMO Stock Technical Analysis Stock Alert, SGMO Stock Technical Analysis How To Read Stock Charts, SGMO Stock Technical Analysis Stock Chart Video, SGMO Stock Technical Analysis Daily Chart, SGMO Stock Technical Analysis Chart Review, SGMO Stock Technical Analysis Stock Review
wn.com/Sangamo Biosciences Sgmo Stock Chart Technical Analysis For 09 11 15
Sangamo Biosciences - SGMO Stock Chart Technical Analysis for 09-11-15
Free Guide - The 5 Tools I Use To Find Stocks To Trade: http://claytrader.com/lp/Free-Guide-Trading-Tools/?utm_source=social&utm;_medium=youtube&utm;_campaign=resource%20guide
Learn how to read stock charts and identify technical patterns as ClayTrader does a quick stock chart review on Sangamo Biosciences (SGMO). Watch more SGMO Technical Analysis Videos: http://claytrader.com/stock_chart/SGMO/
The Stock Trading Reality Podcast - http://claytrader.com/podcast/
ClayTrader.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. Investing/trading in securities is highly speculative and carries an extremely high degree of risk.
SGMO Stock Technical Analysis Stock Chart, SGMO Stock Technical Analysis Stock Pick, SGMO Stock Technical Analysis Penny Stock, SGMO Stock Technical Analysis Penny Stock Pick, SGMO Stock Technical Analysis Stock Alert, SGMO Stock Technical Analysis How To Read Stock Charts, SGMO Stock Technical Analysis Stock Chart Video, SGMO Stock Technical Analysis Daily Chart, SGMO Stock Technical Analysis Chart Review, SGMO Stock Technical Analysis Stock Review
- published: 11 Sep 2015
- views: 28
International Journal on Bioinformatics & Biosciences
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)...
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)
wn.com/International Journal On Bioinformatics Biosciences
I created this video with the YouTube Video Editor (https://www.youtube.com/editor)
- published: 10 Sep 2015
- views: 0
Terry Fodey | Agri-Food and Biosciences Institute | UK | Food Technology 2015 | OMICS International
OMICS International: http://conferenceseries.com/
OMICS open access Journals: http://omicsonline.org
Global Medical Conferences: http://conferenceseries.com
Gl...
OMICS International: http://conferenceseries.com/
OMICS open access Journals: http://omicsonline.org
Global Medical Conferences: http://conferenceseries.com
Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com
Global Cancer Conferences: http://cancersummit.org
Global Diabetes Conferences: http://diabetesexpo.com
Global Dental Conferences: http://dentalcongress.com
Global Nursing Conferences: http://nursingconference.com
Food Technology-2015 welcomes participants, visitors, delegates and exhibitors from all over the world to the idealist city of London, United Kingdom. OMICS International organizes 300+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. OMICS International feel blissful to invite you all to attend “4th International Conference and Exhibition on Food Processing & Technology (Food Technology-2015)” which is going to be held during August 10-12th, 2015 on a theme “Food Technology: Trends and Strategies for Innovation of Sustainable Foods”.
OMICS International Organises 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.
wn.com/Terry Fodey | Agri Food And Biosciences Institute | UK | Food Technology 2015 | Omics International
OMICS International: http://conferenceseries.com/
OMICS open access Journals: http://omicsonline.org
Global Medical Conferences: http://conferenceseries.com
Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com
Global Cancer Conferences: http://cancersummit.org
Global Diabetes Conferences: http://diabetesexpo.com
Global Dental Conferences: http://dentalcongress.com
Global Nursing Conferences: http://nursingconference.com
Food Technology-2015 welcomes participants, visitors, delegates and exhibitors from all over the world to the idealist city of London, United Kingdom. OMICS International organizes 300+ conferences every year across USA, Europe & Asia with support from 1000 more scientific societies and publishes 400+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. OMICS International feel blissful to invite you all to attend “4th International Conference and Exhibition on Food Processing & Technology (Food Technology-2015)” which is going to be held during August 10-12th, 2015 on a theme “Food Technology: Trends and Strategies for Innovation of Sustainable Foods”.
OMICS International Organises 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members.
- published: 08 Sep 2015
- views: 1
Innova Biosciences and Mologic Sign Supply and Licensing Agreement - press release
In this short video Andy Lane, Executive Director at Innova Biosciences, talks about a new supply and licensing agreement between Innova and Mologic covering th...
In this short video Andy Lane, Executive Director at Innova Biosciences, talks about a new supply and licensing agreement between Innova and Mologic covering the use of Innova’s Lightning-Link and InnovaCoat GOLD technologies in Mologic’s kits and services.
For more information and for the full press release, visit our website: https://www.innovabiosciences.com/latest-updates/news/innova-mologic-supply-licensing-agreement
wn.com/Innova Biosciences And Mologic Sign Supply And Licensing Agreement Press Release
In this short video Andy Lane, Executive Director at Innova Biosciences, talks about a new supply and licensing agreement between Innova and Mologic covering the use of Innova’s Lightning-Link and InnovaCoat GOLD technologies in Mologic’s kits and services.
For more information and for the full press release, visit our website: https://www.innovabiosciences.com/latest-updates/news/innova-mologic-supply-licensing-agreement
- published: 02 Sep 2015
- views: 9
The Innova Biosciences Antibody Conjugate Generator - Press Release
In this video Dr Andy Lane, Executive Director at Innova Biosciences, talks about our new online generator which allows you to select from a wide range of antib...
In this video Dr Andy Lane, Executive Director at Innova Biosciences, talks about our new online generator which allows you to select from a wide range of antibodies and conjugate to one of over 24 labels including enzymes, biotin, fluorescent dyes and gold nanoparticles.
For more information on our Antibody Conjugate Generator please visit our website: www.innovabiosciences.com/products/Antibody-Conjugates
wn.com/The Innova Biosciences Antibody Conjugate Generator Press Release
In this video Dr Andy Lane, Executive Director at Innova Biosciences, talks about our new online generator which allows you to select from a wide range of antibodies and conjugate to one of over 24 labels including enzymes, biotin, fluorescent dyes and gold nanoparticles.
For more information on our Antibody Conjugate Generator please visit our website: www.innovabiosciences.com/products/Antibody-Conjugates
- published: 01 Sep 2015
- views: 18
SNNLive - Akers Biosciences, Inc. (NASDAQ: AKER)
SNNLive spoke with Raymond F. Akers, Jr., Ph.D., Executive Chairman of the Board for Akers Biosciences, Inc. (NASDAQ: AKER) at the LD Micro Invitational 2015 in...
SNNLive spoke with Raymond F. Akers, Jr., Ph.D., Executive Chairman of the Board for Akers Biosciences, Inc. (NASDAQ: AKER) at the LD Micro Invitational 2015 in Bel Air, CA.
For more information: http://www.akersbiosciences.com/
wn.com/Snnlive Akers Biosciences, Inc. (Nasdaq Aker)
SNNLive spoke with Raymond F. Akers, Jr., Ph.D., Executive Chairman of the Board for Akers Biosciences, Inc. (NASDAQ: AKER) at the LD Micro Invitational 2015 in Bel Air, CA.
For more information: http://www.akersbiosciences.com/
- published: 26 Aug 2015
- views: 21
Vijaya Rao Pidugu | GVK Biosciences | India | Metabolomics 2014 | OMICS International
Title: Bilirubin as a biological marker for metabolic, cardiovascular and oncological disorders; Analysis using GOBIOM database.
3rd International Conference ...
Title: Bilirubin as a biological marker for metabolic, cardiovascular and oncological disorders; Analysis using GOBIOM database.
3rd International Conference and Exhibition on Metabolomics & Systems Biology
March 24-26, 2014, San Antonio, USA
OMICS International: http://omicsonline.org
Vaccine Conferences: http://conferenceseries.com/immunology-conferences.php
Global Medical Conferences: http://conferenceseries.com
Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com
Global Cancer Conferences: http://cancersummit.org
Global Diabetes Conferences: http://diabetesexpo.com
Global Dental Conferences: http://dentalcongress.com
Global Nursing Conferences: http://nursingconference.com
Abstract
Current advances in biomarker research area are aiding us in the development of new and clinically reliable indicators that will have a high specificity for the diagnosis and prognosis of the disease. The selection of a biomarker should have a biological or therapeutic basis and it should indicate a reliable correlation with the presence, characteristics, or aggressiveness of the disease. High levels of serum bilirubin, the principal product of heme degradation and a powerful antioxidant that suppresses lipid oxidation, have been viewed by clinicians as a marker of liver dysfunction. Epidemiological research has demonstrated an inverse relationship between elevated serum bilirubin levels and the development of CVD and some forms of cancer due to its antioxidant properties. Few studies have shown that this inverse relationship extends to other heart related disease risk factors such as diabetes, metabolic syndrome, peripheral artery disease (PAD), carotid intima-media thickening, and stroke. Our objective was to identify the reliability of Bilirubin as a biochemical diagnostic biomarker in metabolic, cardiovascular and oncological disorders based on the literature that is published on Bilirubin for multiple indications and establish its association with a single disease which is highly sensitive compared to others. To do the analysis, we used the data from GVK BIO Online Biomarker Database (GOBIOM), which is a repository of all clinical, preclinical and exploratory biomarkers reported for various indications. As on today, GOBIOM contains ~30000 known biomarkers data for 900 indications extracted from ~100000 references which includes journals, patents, scientific conferences and clinical trials. We retrieved Bilirubin biomarker data for all the reported indications from GOBIOM database and analyzed the levels of this marker in various indications compared to the healthy controls. Though abnormal Bilirubin levels are widely reported for variety of liver disorders, there are also reports showing its prominent role in other indications like pancreatic cancer, osteoarthritis, appendicitis, allograft rejection etc. Using the analysis tools of GOBIOM, we compared the percentage difference of Bilirubin between the diseased patients and healthy controls for all the reported indications to identify the diagnostic significance of this marker for the given indication.
Biography
Vijaya Rao Pidugu is a scientist in GVK Biosciences Private Limited, a leading contract research organization providing a spectrum of services and solutions such as scientific consulting and contract research services in the areas of Medicinal chemistry, Discovery biology, Informatics, Process R&D;, Clinical research, Clinical data management and Clinical pharmacology. He has been associated with GVKBIO for 10 years and works on GVK BIO Online Biomarker Database (GOBIOM) database. His expertise includes identification of clinical targets, developing strategies for target identification, database optimization, data validation, maintaining data standards and evaluating therapeutic area related datasets.
wn.com/Vijaya Rao Pidugu | Gvk Biosciences | India | Metabolomics 2014 | Omics International
Title: Bilirubin as a biological marker for metabolic, cardiovascular and oncological disorders; Analysis using GOBIOM database.
3rd International Conference and Exhibition on Metabolomics & Systems Biology
March 24-26, 2014, San Antonio, USA
OMICS International: http://omicsonline.org
Vaccine Conferences: http://conferenceseries.com/immunology-conferences.php
Global Medical Conferences: http://conferenceseries.com
Global Pharmaceutical Conferences: http://pharmaceuticalconferences.com
Global Cancer Conferences: http://cancersummit.org
Global Diabetes Conferences: http://diabetesexpo.com
Global Dental Conferences: http://dentalcongress.com
Global Nursing Conferences: http://nursingconference.com
Abstract
Current advances in biomarker research area are aiding us in the development of new and clinically reliable indicators that will have a high specificity for the diagnosis and prognosis of the disease. The selection of a biomarker should have a biological or therapeutic basis and it should indicate a reliable correlation with the presence, characteristics, or aggressiveness of the disease. High levels of serum bilirubin, the principal product of heme degradation and a powerful antioxidant that suppresses lipid oxidation, have been viewed by clinicians as a marker of liver dysfunction. Epidemiological research has demonstrated an inverse relationship between elevated serum bilirubin levels and the development of CVD and some forms of cancer due to its antioxidant properties. Few studies have shown that this inverse relationship extends to other heart related disease risk factors such as diabetes, metabolic syndrome, peripheral artery disease (PAD), carotid intima-media thickening, and stroke. Our objective was to identify the reliability of Bilirubin as a biochemical diagnostic biomarker in metabolic, cardiovascular and oncological disorders based on the literature that is published on Bilirubin for multiple indications and establish its association with a single disease which is highly sensitive compared to others. To do the analysis, we used the data from GVK BIO Online Biomarker Database (GOBIOM), which is a repository of all clinical, preclinical and exploratory biomarkers reported for various indications. As on today, GOBIOM contains ~30000 known biomarkers data for 900 indications extracted from ~100000 references which includes journals, patents, scientific conferences and clinical trials. We retrieved Bilirubin biomarker data for all the reported indications from GOBIOM database and analyzed the levels of this marker in various indications compared to the healthy controls. Though abnormal Bilirubin levels are widely reported for variety of liver disorders, there are also reports showing its prominent role in other indications like pancreatic cancer, osteoarthritis, appendicitis, allograft rejection etc. Using the analysis tools of GOBIOM, we compared the percentage difference of Bilirubin between the diseased patients and healthy controls for all the reported indications to identify the diagnostic significance of this marker for the given indication.
Biography
Vijaya Rao Pidugu is a scientist in GVK Biosciences Private Limited, a leading contract research organization providing a spectrum of services and solutions such as scientific consulting and contract research services in the areas of Medicinal chemistry, Discovery biology, Informatics, Process R&D;, Clinical research, Clinical data management and Clinical pharmacology. He has been associated with GVKBIO for 10 years and works on GVK BIO Online Biomarker Database (GOBIOM) database. His expertise includes identification of clinical targets, developing strategies for target identification, database optimization, data validation, maintaining data standards and evaluating therapeutic area related datasets.
- published: 21 Aug 2015
- views: 1
Biosciences and chemistry – student and tutor in conversation
Dr David Smith, senior lecturer in biochemistry, talks to Vietnamese student Dinh about his experience of Sheffield Hallam.
Do you want to study in the UK? Find...
Dr David Smith, senior lecturer in biochemistry, talks to Vietnamese student Dinh about his experience of Sheffield Hallam.
Do you want to study in the UK? Find out more about joining our vibrant and friendly student community – http://www.shu.ac.uk/international
wn.com/Biosciences And Chemistry – Student And Tutor In Conversation
Dr David Smith, senior lecturer in biochemistry, talks to Vietnamese student Dinh about his experience of Sheffield Hallam.
Do you want to study in the UK? Find out more about joining our vibrant and friendly student community – http://www.shu.ac.uk/international
- published: 20 Aug 2015
- views: 32
International Conference on Biosciences 2015 (Courtesy of GreenTV IPB)
original link: http://greentv.ipb.ac.id/videos/international-confrenece-on-bioscience-2015/
conference information: http://www.icobio.event.ipb.ac.id...
original link: http://greentv.ipb.ac.id/videos/international-confrenece-on-bioscience-2015/
conference information: http://www.icobio.event.ipb.ac.id
wn.com/International Conference On Biosciences 2015 (Courtesy Of Greentv Ipb)
original link: http://greentv.ipb.ac.id/videos/international-confrenece-on-bioscience-2015/
conference information: http://www.icobio.event.ipb.ac.id
- published: 20 Aug 2015
- views: 41
-
Gajus Worthington, CEO, Fluidigm Corporation, Select Biosciences Single-Cell Analysis Summit Keynote
In September 2014, Gajus Worthington, Co-Founder, President & CEO, Fluidigm Corporation, gave the keynote presentation at the Select Biosciences Single Cell Analysis Summit in San Diego, California. Entitled “Single-Cell Biology: Changing our Understanding of Fundamental Molecular Mechanisms in Life Sciences,” the audience was introduced to breakthroughs in single-cell biology, particularly single
-
Energy Biosciences Institute Seminar - Richard Muller
UC Berkeley Distinguished Teaching Award-winning Physicist Richard Muller, whose expertise spans astrophysics, geophysics, ice ages and death stars, discusse...
-
IP Law and the Biosciences Conference | Patentable Subject Matter
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Biosciences.
The conference brought together leading experts from academia, industry and the judiciary on the latest developments in intellectual property law and the biosciences.
In the panel, "Patentable Subject Matter" Jeff Oelke, Partner, Wh
-
IP Law and the Biosciences | Patent Litigation in the Biosciences: A View from the Bench
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf...
-
Bioscience Discoveries That Will Blow Your Mind
Updated version at - http://www.youtube.com/watch?v=VeW1a475rFE Speakers: Jack Andraka, Student Inventor, Scientist and Cancer Researcher; 2012 Intel Science...
-
Akers Biosciences (NASDAQCM: AKER) - RedChip Global Online CEO Conference
Presentation and Investor Q&A; with Ray Akers, Executive Chairman of Akers Biosciences (NASDAQCM: AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products, discusses the company at the RedChip Global Online CEO Conference (October 15-16, 2014).
-
KCU - Kansas City University of Medicine and Biosciences
The Kansas City University of Medicine and Biosciences (KCU) marked the commencement of a new era on March 26, 2015, with the investiture of Marc B. Hahn, DO, FAOCA, as its fourteenth president and the announcement of an additional campus in Joplin, Mo.
-
IP Law and the Biosciences Conference | Solutions to the Biotech Patent Thicket
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Bioscie...
-
Chris Somerville (Energy Biosciences Institute, UC Berkeley/LBNL) Part 2: Cellulosic Biofuels
In the second segment, the potential for various types of biofuels are compared and some of the technical challenges in production of cellulosic fuels are ou...
-
2013 HIV AIDS "Functional Cure" Conference Update 1 Sangamo BioSciences, Inc.
Leerink Swann Global Healthcare Conference Speaker: Edward Lanphier, President and CEO.
-
Jeff Olson Signum Biosciences Derma Announcement
-
Energy Biosciences Institute Seminar - Terry Hazen
Terry Hazen Ecology Dept. and Center for Environmental Biotechnology Lawrence Berkeley National Laboratory Topic: Bioremediation Host: Kelly Wetmor.
-
This Week on RedChip TV: Dave Gentry Interviews Arch Therapeutics, Akers Biosciences, and Calpian
The March 1, 2015 episode of “The RedChip Money Report: Small Stocks, Big Money” features interviews with Dr. Terrence Norchi, CEO of Arch Therapeutics (OTCQB: ARCH), a medical device company using a novel approach to stop surgical bleeding; Raymond Akers, CEO of Akers Biosciences (Nasdaq: AKER), developer and distributor of rapid point-of-care diagnostic testing devices; and Harold Montgomery, Ch
-
Energy Biosciences Institute Seminar - Scott E. Baker
"Fungi, Genomes, Enzymes and Metabolites" Scott E. Baker, a scientist at Pacific Northwest National Laboratory, who is an authority on the biology of fungi. ...
-
Energy Biosciences Institute Seminar - David B. Wilson
"Mechanistic Studies of Thermobifida fusca Cellulases" David B. Wilson Professor, Department of Molecular Biology and Genetics, Cornell University.
-
Akers Biosciences, Opexa Therapeutics, North Star Funds on The RedChip Money Report
This week's show features interviews with Ray Akers, CEO of Akers Biosciences, Inc. (NasdaqCM: AKER), a leading designer and manufacturer of rapid diagnostic...
-
Energy Biosciences Institute Seminar - Henrik Scheller
"Optimizing Cell Wall Biosynthesis for Biofuel Production" Henrik Scheller, Biological Engineer and Senior Scientist at the DOE Joint BioEnergy Institute (JB...
-
IP Law and the Biosciences | Indefiniteness and Functional Claiming
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf...
-
Energy Biosciences Institute Seminar -Justin Stege
"Verenium Lignocellulosic Enzyme R&D;" Justin Stege is currently the Director of Biofuels Research at Verenium Corp. in San Diego. His research is focused on ...
-
Energy Biosciences Institute Seminar - Wolfgang Holderich
Wolfgang Holderich's seminar is entitled "The Use of Renewable Feedstocks as a Contribution for Environmental Protection." Energy Biosciences Institute http:...
-
Energy Biosciences Institute Seminar - Stephen Del Cardayre
"One-Step Conversion of Sugar to Drop-In Renewable Fuels and Chemicals" Stephen Del Cardayre, vice president for research and development at LS9, the renewab...
Gajus Worthington, CEO, Fluidigm Corporation, Select Biosciences Single-Cell Analysis Summit Keynote
In September 2014, Gajus Worthington, Co-Founder, President & CEO, Fluidigm Corporation, gave the keynote presentation at the Select Biosciences Single Cell Ana...
In September 2014, Gajus Worthington, Co-Founder, President & CEO, Fluidigm Corporation, gave the keynote presentation at the Select Biosciences Single Cell Analysis Summit in San Diego, California. Entitled “Single-Cell Biology: Changing our Understanding of Fundamental Molecular Mechanisms in Life Sciences,” the audience was introduced to breakthroughs in single-cell biology, particularly single cell genomics and proteomics, as Worthington explained how this emerging area of life sciences is changing our understanding of fundamental molecular mechanisms in many areas of life science research.
wn.com/Gajus Worthington, Ceo, Fluidigm Corporation, Select Biosciences Single Cell Analysis Summit Keynote
In September 2014, Gajus Worthington, Co-Founder, President & CEO, Fluidigm Corporation, gave the keynote presentation at the Select Biosciences Single Cell Analysis Summit in San Diego, California. Entitled “Single-Cell Biology: Changing our Understanding of Fundamental Molecular Mechanisms in Life Sciences,” the audience was introduced to breakthroughs in single-cell biology, particularly single cell genomics and proteomics, as Worthington explained how this emerging area of life sciences is changing our understanding of fundamental molecular mechanisms in many areas of life science research.
- published: 09 Dec 2014
- views: 6
Energy Biosciences Institute Seminar - Richard Muller
UC Berkeley Distinguished Teaching Award-winning Physicist Richard Muller, whose expertise spans astrophysics, geophysics, ice ages and death stars, discusse......
UC Berkeley Distinguished Teaching Award-winning Physicist Richard Muller, whose expertise spans astrophysics, geophysics, ice ages and death stars, discusse...
wn.com/Energy Biosciences Institute Seminar Richard Muller
UC Berkeley Distinguished Teaching Award-winning Physicist Richard Muller, whose expertise spans astrophysics, geophysics, ice ages and death stars, discusse...
IP Law and the Biosciences Conference | Patentable Subject Matter
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Bioscienc...
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Biosciences.
The conference brought together leading experts from academia, industry and the judiciary on the latest developments in intellectual property law and the biosciences.
In the panel, "Patentable Subject Matter" Jeff Oelke, Partner, White & Case LLP moderated a discussion with John Duffy, Armistead M. Dobie Professor of Law,
University of Virginia, School of Law, Mark Lemley, William H. Neukom Professor; Director, Stanford Program in Law, Science, and Technology, Stanford Law School; Partner, Durie Tangri LLP , Dan Ravicher, Executive Director, Public Patent
Foundation; Lecturer in Law, Cardozo Law School and Seth P. Waxman, Partner, WilmerHale
wn.com/Ip Law And The Biosciences Conference | Patentable Subject Matter
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Biosciences.
The conference brought together leading experts from academia, industry and the judiciary on the latest developments in intellectual property law and the biosciences.
In the panel, "Patentable Subject Matter" Jeff Oelke, Partner, White & Case LLP moderated a discussion with John Duffy, Armistead M. Dobie Professor of Law,
University of Virginia, School of Law, Mark Lemley, William H. Neukom Professor; Director, Stanford Program in Law, Science, and Technology, Stanford Law School; Partner, Durie Tangri LLP , Dan Ravicher, Executive Director, Public Patent
Foundation; Lecturer in Law, Cardozo Law School and Seth P. Waxman, Partner, WilmerHale
- published: 22 May 2012
- views: 821
IP Law and the Biosciences | Patent Litigation in the Biosciences: A View from the Bench
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf......
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf...
wn.com/Ip Law And The Biosciences | Patent Litigation In The Biosciences A View From The Bench
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf...
Bioscience Discoveries That Will Blow Your Mind
Updated version at - http://www.youtube.com/watch?v=VeW1a475rFE Speakers: Jack Andraka, Student Inventor, Scientist and Cancer Researcher; 2012 Intel Science......
Updated version at - http://www.youtube.com/watch?v=VeW1a475rFE Speakers: Jack Andraka, Student Inventor, Scientist and Cancer Researcher; 2012 Intel Science...
wn.com/Bioscience Discoveries That Will Blow Your Mind
Updated version at - http://www.youtube.com/watch?v=VeW1a475rFE Speakers: Jack Andraka, Student Inventor, Scientist and Cancer Researcher; 2012 Intel Science...
Akers Biosciences (NASDAQCM: AKER) - RedChip Global Online CEO Conference
Presentation and Investor Q&A; with Ray Akers, Executive Chairman of Akers Biosciences (NASDAQCM: AKER), a leading designer and manufacturer of rapid diagnostic ...
Presentation and Investor Q&A; with Ray Akers, Executive Chairman of Akers Biosciences (NASDAQCM: AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products, discusses the company at the RedChip Global Online CEO Conference (October 15-16, 2014).
wn.com/Akers Biosciences (Nasdaqcm Aker) Redchip Global Online Ceo Conference
Presentation and Investor Q&A; with Ray Akers, Executive Chairman of Akers Biosciences (NASDAQCM: AKER), a leading designer and manufacturer of rapid diagnostic screening and testing products, discusses the company at the RedChip Global Online CEO Conference (October 15-16, 2014).
- published: 17 Oct 2014
- views: 519
KCU - Kansas City University of Medicine and Biosciences
The Kansas City University of Medicine and Biosciences (KCU) marked the commencement of a new era on March 26, 2015, with the investiture of Marc B. Hahn, DO, F...
The Kansas City University of Medicine and Biosciences (KCU) marked the commencement of a new era on March 26, 2015, with the investiture of Marc B. Hahn, DO, FAOCA, as its fourteenth president and the announcement of an additional campus in Joplin, Mo.
wn.com/Kcu Kansas City University Of Medicine And Biosciences
The Kansas City University of Medicine and Biosciences (KCU) marked the commencement of a new era on March 26, 2015, with the investiture of Marc B. Hahn, DO, FAOCA, as its fourteenth president and the announcement of an additional campus in Joplin, Mo.
- published: 31 Mar 2015
- views: 74
IP Law and the Biosciences Conference | Solutions to the Biotech Patent Thicket
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Bioscie......
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Bioscie...
wn.com/Ip Law And The Biosciences Conference | Solutions To The Biotech Patent Thicket
On April 27th, 2012 the Stanford Program in Law Science and Technology hosted the Stanford Law School Conference on Intellectual Property Law and the Bioscie...
Chris Somerville (Energy Biosciences Institute, UC Berkeley/LBNL) Part 2: Cellulosic Biofuels
In the second segment, the potential for various types of biofuels are compared and some of the technical challenges in production of cellulosic fuels are ou......
In the second segment, the potential for various types of biofuels are compared and some of the technical challenges in production of cellulosic fuels are ou...
wn.com/Chris Somerville (Energy Biosciences Institute, Uc Berkeley Lbnl) Part 2 Cellulosic Biofuels
In the second segment, the potential for various types of biofuels are compared and some of the technical challenges in production of cellulosic fuels are ou...
- published: 04 Jun 2010
- views: 1355
-
author: iBiology
2013 HIV AIDS "Functional Cure" Conference Update 1 Sangamo BioSciences, Inc.
Leerink Swann Global Healthcare Conference Speaker: Edward Lanphier, President and CEO....
Leerink Swann Global Healthcare Conference Speaker: Edward Lanphier, President and CEO.
wn.com/2013 Hiv Aids Functional Cure Conference Update 1 Sangamo Biosciences, Inc.
Leerink Swann Global Healthcare Conference Speaker: Edward Lanphier, President and CEO.
- published: 17 Feb 2013
- views: 2908
-
author: pozfriends
Energy Biosciences Institute Seminar - Terry Hazen
Terry Hazen Ecology Dept. and Center for Environmental Biotechnology Lawrence Berkeley National Laboratory Topic: Bioremediation Host: Kelly Wetmor....
Terry Hazen Ecology Dept. and Center for Environmental Biotechnology Lawrence Berkeley National Laboratory Topic: Bioremediation Host: Kelly Wetmor.
wn.com/Energy Biosciences Institute Seminar Terry Hazen
Terry Hazen Ecology Dept. and Center for Environmental Biotechnology Lawrence Berkeley National Laboratory Topic: Bioremediation Host: Kelly Wetmor.
This Week on RedChip TV: Dave Gentry Interviews Arch Therapeutics, Akers Biosciences, and Calpian
The March 1, 2015 episode of “The RedChip Money Report: Small Stocks, Big Money” features interviews with Dr. Terrence Norchi, CEO of Arch Therapeutics (OTCQB: ...
The March 1, 2015 episode of “The RedChip Money Report: Small Stocks, Big Money” features interviews with Dr. Terrence Norchi, CEO of Arch Therapeutics (OTCQB: ARCH), a medical device company using a novel approach to stop surgical bleeding; Raymond Akers, CEO of Akers Biosciences (Nasdaq: AKER), developer and distributor of rapid point-of-care diagnostic testing devices; and Harold Montgomery, Chairman and CEO, of Calpian (OTCQB: CLPI), a global provider of mobile payment and processing solutions.
“The RedChip Money Report: Small Stocks, Big Money” delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of microcap and small-cap public companies. The weekly program airs on Bloomberg Europe, Bloomberg Asia, and Newsmax (available on DIRECTV and Dish Network). For more information, visit: http://www.redchip.com/tv
wn.com/This Week On Redchip Tv Dave Gentry Interviews Arch Therapeutics, Akers Biosciences, And Calpian
The March 1, 2015 episode of “The RedChip Money Report: Small Stocks, Big Money” features interviews with Dr. Terrence Norchi, CEO of Arch Therapeutics (OTCQB: ARCH), a medical device company using a novel approach to stop surgical bleeding; Raymond Akers, CEO of Akers Biosciences (Nasdaq: AKER), developer and distributor of rapid point-of-care diagnostic testing devices; and Harold Montgomery, Chairman and CEO, of Calpian (OTCQB: CLPI), a global provider of mobile payment and processing solutions.
“The RedChip Money Report: Small Stocks, Big Money” delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of microcap and small-cap public companies. The weekly program airs on Bloomberg Europe, Bloomberg Asia, and Newsmax (available on DIRECTV and Dish Network). For more information, visit: http://www.redchip.com/tv
- published: 03 Mar 2015
- views: 2066
Energy Biosciences Institute Seminar - Scott E. Baker
"Fungi, Genomes, Enzymes and Metabolites" Scott E. Baker, a scientist at Pacific Northwest National Laboratory, who is an authority on the biology of fungi. ......
"Fungi, Genomes, Enzymes and Metabolites" Scott E. Baker, a scientist at Pacific Northwest National Laboratory, who is an authority on the biology of fungi. ...
wn.com/Energy Biosciences Institute Seminar Scott E. Baker
"Fungi, Genomes, Enzymes and Metabolites" Scott E. Baker, a scientist at Pacific Northwest National Laboratory, who is an authority on the biology of fungi. ...
Energy Biosciences Institute Seminar - David B. Wilson
"Mechanistic Studies of Thermobifida fusca Cellulases" David B. Wilson Professor, Department of Molecular Biology and Genetics, Cornell University....
"Mechanistic Studies of Thermobifida fusca Cellulases" David B. Wilson Professor, Department of Molecular Biology and Genetics, Cornell University.
wn.com/Energy Biosciences Institute Seminar David B. Wilson
"Mechanistic Studies of Thermobifida fusca Cellulases" David B. Wilson Professor, Department of Molecular Biology and Genetics, Cornell University.
Akers Biosciences, Opexa Therapeutics, North Star Funds on The RedChip Money Report
This week's show features interviews with Ray Akers, CEO of Akers Biosciences, Inc. (NasdaqCM: AKER), a leading designer and manufacturer of rapid diagnostic......
This week's show features interviews with Ray Akers, CEO of Akers Biosciences, Inc. (NasdaqCM: AKER), a leading designer and manufacturer of rapid diagnostic...
wn.com/Akers Biosciences, Opexa Therapeutics, North Star Funds On The Redchip Money Report
This week's show features interviews with Ray Akers, CEO of Akers Biosciences, Inc. (NasdaqCM: AKER), a leading designer and manufacturer of rapid diagnostic...
Energy Biosciences Institute Seminar - Henrik Scheller
"Optimizing Cell Wall Biosynthesis for Biofuel Production" Henrik Scheller, Biological Engineer and Senior Scientist at the DOE Joint BioEnergy Institute (JB......
"Optimizing Cell Wall Biosynthesis for Biofuel Production" Henrik Scheller, Biological Engineer and Senior Scientist at the DOE Joint BioEnergy Institute (JB...
wn.com/Energy Biosciences Institute Seminar Henrik Scheller
"Optimizing Cell Wall Biosynthesis for Biofuel Production" Henrik Scheller, Biological Engineer and Senior Scientist at the DOE Joint BioEnergy Institute (JB...
IP Law and the Biosciences | Indefiniteness and Functional Claiming
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf......
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf...
wn.com/Ip Law And The Biosciences | Indefiniteness And Functional Claiming
On May 16, 2014, Stanford's Program in Law, Science & Technology and the Center for Law and the Biosciences hosted Stanford's IP Law and the Biosciences Conf...
Energy Biosciences Institute Seminar -Justin Stege
"Verenium Lignocellulosic Enzyme R&D;" Justin Stege is currently the Director of Biofuels Research at Verenium Corp. in San Diego. His research is focused on ......
"Verenium Lignocellulosic Enzyme R&D;" Justin Stege is currently the Director of Biofuels Research at Verenium Corp. in San Diego. His research is focused on ...
wn.com/Energy Biosciences Institute Seminar Justin Stege
"Verenium Lignocellulosic Enzyme R&D;" Justin Stege is currently the Director of Biofuels Research at Verenium Corp. in San Diego. His research is focused on ...
Energy Biosciences Institute Seminar - Wolfgang Holderich
Wolfgang Holderich's seminar is entitled "The Use of Renewable Feedstocks as a Contribution for Environmental Protection." Energy Biosciences Institute http:......
Wolfgang Holderich's seminar is entitled "The Use of Renewable Feedstocks as a Contribution for Environmental Protection." Energy Biosciences Institute http:...
wn.com/Energy Biosciences Institute Seminar Wolfgang Holderich
Wolfgang Holderich's seminar is entitled "The Use of Renewable Feedstocks as a Contribution for Environmental Protection." Energy Biosciences Institute http:...
Energy Biosciences Institute Seminar - Stephen Del Cardayre
"One-Step Conversion of Sugar to Drop-In Renewable Fuels and Chemicals" Stephen Del Cardayre, vice president for research and development at LS9, the renewab......
"One-Step Conversion of Sugar to Drop-In Renewable Fuels and Chemicals" Stephen Del Cardayre, vice president for research and development at LS9, the renewab...
wn.com/Energy Biosciences Institute Seminar Stephen Del Cardayre
"One-Step Conversion of Sugar to Drop-In Renewable Fuels and Chemicals" Stephen Del Cardayre, vice president for research and development at LS9, the renewab...